Establishment of PLGA Research Program at Dana Farber Cancer Institute

In May 2007, PLGA Fund at PBTF funded the establishment of the first dedicated PLGA research program at the Dana Farber Cancer Institute. The initial $2 million grant helped concentrate resources on research into pediatric low-grade brain tumors in order to discover new and improved targeted therapies that don’t risk impairing children’s bodies and minds. This is believed to be the first coordinated research effort committed to this specific type of tumor worldwide. This flagship program, under the direction of Charles Stiles, PhD, and Mark Kieran, MD, PhD, drew resources, including personnel and technology, from Dana-Farber’s pediatric neuro-oncology program, the Department of Neurobiology at Harvard Medical School, Children’s Hospital Boston, and the Broad Institute of MIT and Harvard. Since its founding more than 10 years ago, the program has advanced the study of PLGA tumors through genomics, drug development, and tumor micro-environment research, as well as clinical trials and tissue banking initiatives. Learn more about the program at https://danafarberplga.org.

Funded in 2007.